Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease
CHEST · 2026-08 · 170 (2) · 432-443
DOI: 10.1016/j.chest.2026.01.022 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift CHEST, 2026-08. Verfasst von Handan Kekec und 51 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Pulmonary Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Childhood interstitial lung diseases (chILDs) encompass a wide range of rare, chronic respiratory disorders, with pulmonary fibrosis (PF) being the clinical entity closely associated with mortality and morbidity. RESEARCH QUESTION: What is the prevalence and radiologic spectrum of PF in children with chILD, and how is it associated with pulmonary function and clinical characteristics? STUDY DESIGN AND METHODS: This multicenter, retrospective observational cohort study used data from the Turkish Childhood Interstitial Lung Disease Registry as of January 2024. An experienced radiologist reviewed the chest CT scans for PF findings. Patients were divided into 2 groups based on the presence or absence of PF findings, and their clinical and demographic data were analyzed. RESULTS: A total of 404 patients (47.5% female) from 25 centers were included. The median age was 137 months (interquartile range [IQR], 24-376 months). The median z score for weight was -1.02 (IQR, -8.8 to 6.88), and the median z score for height was -0.59 (IQR, -7 to 6.45). The median FEV1 was 68% (IQR, 16%-127%), and the median diffusion capacity of the lungs for carbon monoxide (Dlco) was 66% (IQR, 21%-132%). The PF findings were as follows: reticular abnormalities, 34.9% of patients; cystic abnormalities, 21% of patients; traction bronchiectasis, 19.8% of patients; architectural distortion, 14.4% of patients; and honeycombing, 2.5% of patients. Two groups were compared based on the presence (n = 183) or absence (n = 221) of PF findings; the group with fibrotic findings showed a higher age and lower z score for weight (P .05), Dlco was lower in the fibrotic group (P = .015). The prevalence of PF was higher in patients with diffuse parenchymal lung disease (DPLD) group A disorders than in those with DPLD group B (P = .014). INTERPRETATION: Our results show that PF is a common complication in chILD and becomes more pronounced with age, underscoring the importance of early detection. The higher rate of PF findings in patients with DPLD-A disorders suggests that children with surfactant dysfunction or alveolar developmental abnormalities may be at an increased risk of PF developing. PF may be more common in children with a lower Dlco score, with a DPLD-A disorder, or of an older age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.
- Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey. Electronic address: tanaaslan@gazi.edu.tr.
- Department of Radiology, Gazi University Faculty of Medicine, Ankara, Turkey.
- Department of Pediatric Pulmonology, Faculty of Medicine, Medeniyet University, İstanbul, Turkey.
- Department of Pediatric Pulmonology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- Department of Pediatric Pulmonology, Faculty of Medicine, Ege University, Izmır, Turkey.
Zitieren
APA
Kekec, H., Aslan, A. T., Akdulum, I., Eyuboglu, T. S., Ulgen, O., Mocan, Y., Oksay, S. C., Dogru, D., Ozcelık, U., Erdal, M. A., Gulen, F., Dindar, B. G., Ocak, E., Ayman, F. N., Tokdemir, B. E., Unal, G., Zirek, F., Olgun, E. G., Tekin, M. N., …, & Kiper, N. (2026). Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease. CHEST, 170(2), 432-443. https://doi.org/10.1016/j.chest.2026.01.022
Vancouver
Kekec H, Aslan AT, Akdulum I, Eyuboglu TS, Ulgen O, Mocan Y, et al. Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease. CHEST. 2026;170(2):432-443. doi:10.1016/j.chest.2026.01.022
BibTeX
@article{Kekec2026,
author = {Kekec, Handan and Aslan, Ayse Tana and Akdulum, Ismail and Eyuboglu, Tugba Sismanlar and Ulgen, Ozge and Mocan, Yasemin and Oksay, Sinem Can and Dogru, Deniz and Ozcelık, Ugur and Erdal, Meltem Akgul and Gulen, Figen and Dindar, Bahar Girgin and Ocak, Ece and Ayman, Fatma Nur and Tokdemir, Bahar Ece and Unal, Gökçen and Zirek, Fazılcan and Olgun, Esin Gizem and Tekin, Merve Nur and Bingol, Aysen and Basaran, Abdurrahman Erdem and Parlak, Betül Bankoglu and Karadağ, Bülent and Balcı, Merve Selcuk and Ergenekon, Almala Pınar and Kose, Mehmet and Ersoy, Ali and Yıldırım, Celebi and Tugcu, Goksen Dilşa and Ozsezen, Beste and Uyan, Zeynep Seda and Ucar, Ayşe Kalyoncu and Gursoy, Tuğba Ramaslı and Serbes, Mahir and Oktem, Sedat and Asfuroglu, Pelin and Hangul, Melih and Buyuksahın, Halime Nayır and Hızal, Mina and Ozturk, Gokcen Kartal and Sakallı, Ayşe Ayzıt Kılınc and Yalcın, Ebru and Girit, Saniye and Pekcan, Sevgi and Emiralioglu, Nagehan and Cobanoglu, Nazan and Cinel, Güzin and Gökdemir, Yasemin and Orhan, Diclehan and Ceylan, Ahmet Cevdet and Oguz, Berna and Kiper, Nural},
title = {Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease},
journal = {CHEST},
year = {2026},
volume = {170},
number = {2},
pages = {432--443},
doi = {10.1016/j.chest.2026.01.022}
}
EUVIMED